Indapta Therapeutics is a privately held clinical stage biotechnology company developing next-generation cell therapies for the treatment of cancer and autoimmune diseases. The company focuses on developing and bringing to market a diverse pipeline of cell therapies to treat the still unmet medical needs of patients with blood and solid-tumor cancers as well as autoimmune diseases.
Market
Cancer and autoimmune diseases
Location
Houston,
Texas,
USA
Coinvestors
RA Capital Management, LP, Leaps by Bayer, Vertex Ventures HC, Pontifax, Myeloma Investment Fund